Science Magazine said a topical combination of flavesone and abametapir quickly wiped out the mites and eggs that cause scabies with a single dose, and cured infections more quickly than ivermectin in pigs, according to a post the outlet shared on X.
That is the full development supported by the supplied evidence. The post describes flavesone as a mite-killing compound and abametapir as an ovicidal drug, meaning it targets eggs. In that summary, the apparent appeal of the combination is straightforward: a treatment that hits both mites and eggs could make a one-dose approach more effective against scabies than treatments that leave eggs behind. The same post also frames ivermectin as the comparison point in pigs.
What the supplied material does not show is just as important. The packet does not include the underlying study, its methods, sample size, publication details, measured timing, safety information, or any evidence that the treatment has been tested in humans. So the supported takeaway here is narrow: Science Magazine highlighted preclinical-looking results in pigs, not a demonstrated new standard of care for people.
Scabies is caused by mites, and one reason it can be difficult to treat is that eggs can survive and lead to reinfestation. That is why the egg-killing part of Science Magazine's summary stands out. But without the linked paper or a fuller study summary in the packet, the evidence here supports reporting only the attributed claim that this combination performed well in pigs and outpaced ivermectin in that comparison.
Readers should treat this as an early research snapshot rather than a confirmed change in human treatment. Based on the supplied evidence alone, the notable development is that Science Magazine drew attention to a single-dose topical combo that appeared to clear scabies mites and eggs, and to do so faster than ivermectin in pigs.
Source: Science Magazine's post on X
Comments